State Street Corp Seagen Inc. Transaction History

State Street Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $4.83 Million - $5.45 Million	25,204 Added 0.76%	3,359,408 $713 Million
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $3.76 Million - $4.13 Million	-20,028 Reduced 0.6%	3,334,204 $642 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $24.6 Million - $39.1 Million	-192,621 Reduced 5.43%	3,354,232 $679 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $10.7 Million - $12.7 Million	90,920 Added 2.63%	3,546,853 $456 Million
Q3 2022 Nov 15, 2022	BUY	$135.27 - $180.11 $271,757 - $361,840	2,009 Added 0.06%	3,455,933 $473 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $7.78 Million - $12.8 Million	-71,487 Reduced 2.03%	3,453,924 $611 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $2.97 Million - $3.92 Million	24,853 Added 0.71%	3,525,411 $508 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $26.4 Million - $35.3 Million	185,093 Added 5.58%	3,500,558 $541 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $14.1 Million - $16.8 Million	98,812 Added 3.07%	3,315,465 $563 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $40.9 Million - $48.7 Million	302,448 Added 10.38%	3,216,653 $508 Million
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $3.26 Million - $4.53 Million	-23,740 Reduced 0.81%	2,914,205 $405 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $484 Million - $623 Million	2,937,945 New	2,937,945 $515 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.